Sign in

Nabil Gutierrez

Research Analyst at Bank of America Corp. /de/

Nabil Gutierrez is a Research Analyst at Bank of America with a focus on healthcare sector coverage, specifically engaging with companies like Amedisys. His recent activity includes participating in earnings calls and providing analytical insights to support investment decisions, though public data on his performance metrics such as success rates or external rankings is limited. Gutierrez began his analyst role at Bank of America and there is no information available on prior professional experience or notable industry recognitions. His professional credentials and securities licenses are not publicly disclosed, and no details regarding FINRA registration are found.

Nabil Gutierrez's questions to AMEDISYS (AMED) leadership

Question · Q2 2022

Nabil Gutierrez, on for Joanna Gajuk at Bank of America, asked about the company's assumptions for Hospice census growth for the remainder of the year.

Answer

President and CEO Chris Gerard stated that Amedisys expects Hospice census to continue its growth trajectory, showing both sequential and year-over-year increases for the rest of 2022. This confidence is based on stabilizing discharge rates, a consistent median length of stay, and a strategic focus on more stable referral sources like physicians and the community.

Ask follow-up questions

Fintool

Fintool can predict AMEDISYS logo AMED's earnings beat/miss a week before the call

Let Fintool AI Agent track Nabil Gutierrez for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free